Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.
about
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenAddition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in childrenLong-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthmaLeukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysisNose and lungs: one way, one diseaseEfficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma.Treatment of congestion in upper respiratory diseases.Allergic rhinitis: evidence for impact on asthmaRates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis.Hay fever in adolescents and adults.The role of inhaled and/or nasal corticosteroids on the bronchodilator responseManaging co-morbid asthma with allergic rhinitis: targeting the one-airway with leukotriene receptor antagonists.Montelukast in allergic rhinitis: a systematic review and meta-analysis.Novel therapeutic interventions for allergic rhinitis.Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots.Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN.The effect of combined medical treatment on quality of life in persistent allergic rhinitisComparison of Oral Montelukast and Intranasal Fluticasone in Patients with Asthma and Allergic Rhinitis.Rhinosinusitis and asthma: the missing link.The link between allergic rhinitis and asthma: the united airways disease.Impact of comorbidities on asthma.The investigation of severe asthma to define phenotypes.Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities.Nasobronchial interaction.Reply: To PMID 25174863.Treating allergic rhinitis and asthma: different sides of the same fence.Lack of control of severe asthma is associated with co-existence of moderate-to-severe rhinitis.Nasal steroids improve regulation of nasal patency in asthma and mild rhinitis: a randomised, cross-over trial.Effect of an intranasal corticosteroid on exercise induced bronchoconstriction in asthmatic children.
P2860
Q24197682-6C507D54-B8D0-436D-9697-ABA180398560Q24239922-95DFEC65-3F04-465E-B7E4-E9E5F729335EQ24244152-E5D61799-7503-4520-BE59-B9A30E107972Q26782714-330951EF-C4EA-4B41-BD16-DE8769648FA0Q27027525-BEEF5A1D-B6FE-4371-BAFF-B81071CB48DDQ30360466-DECBD6BE-3BB0-483A-9009-644AAAAF62DCQ30481520-20FCAA2D-BA63-4202-82BE-7FFD26C6F8AAQ33265228-1DE29BEF-AA94-468A-A97B-E1D7494D443AQ33424090-74A86207-9C6D-4C78-AF75-9E18C2B46E4BQ33949990-DB26E889-7978-48FB-9950-31F154E080AFQ34449144-B6DB4A55-77B9-46C3-A93B-42B59774FDACQ36371018-E8F8233D-AA53-4FB9-B42C-909114B5E373Q36609797-A6273AE8-C6B5-4F46-A872-D1C793F3C6D4Q36654345-F567710E-994E-4C7F-A74F-8C341E115566Q36719113-53BB31F9-D79A-4CF6-91D7-C107249A57FDQ36966123-91888603-B259-4D22-8AA5-4B8D59E73F09Q37083339-E3ABA9DF-DC4F-44A3-812B-FB88F6C59421Q37266464-DB1E215D-DFB5-49D7-B5D1-46F57949AE64Q37349071-C4FB009F-C7B6-414C-8B52-9E79E0DC2979Q37742100-BC8EB6E7-B7E0-4260-AC5F-5EC85297B790Q37754787-578EF8AB-3853-4147-AA8A-051EA51F03F6Q38003661-87576ADA-CC98-420C-9EEC-17D67557F3D6Q38099379-5DB1E6E5-2758-4436-BD2F-7C9AAF53EA03Q38120057-685C6336-BFAC-4612-9B3F-67809F7E1861Q38532047-388BD1C8-B6B5-4611-97B7-5D31F299031AQ42361258-6B771112-B8C9-48BC-BDCB-9E1FA8100EDAQ43836540-B11EB140-01CB-482D-8C81-9DC41B5E92ADQ45383676-A8EB1D6E-87A3-4852-8260-6EA8796DD9F4Q48276661-22FC277F-EA1E-4187-B400-88566100C9A4Q48518713-8EF361AB-D8E2-48C4-A475-E36D24F50E4A
P2860
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Fluticasone propionate nasal s ...... ffects overall asthma control.
@en
Fluticasone propionate nasal s ...... ffects overall asthma control.
@nl
type
label
Fluticasone propionate nasal s ...... ffects overall asthma control.
@en
Fluticasone propionate nasal s ...... ffects overall asthma control.
@nl
prefLabel
Fluticasone propionate nasal s ...... ffects overall asthma control.
@en
Fluticasone propionate nasal s ...... ffects overall asthma control.
@nl
P2093
P356
P1433
P1476
Fluticasone propionate nasal s ...... ffects overall asthma control.
@en
P2093
Barbara A Prillaman
Edward Philpot
Harold S Nelson
John L Stauffer
Kelli Waitkus-Edwards
Paul M Dorinsky
Robert A Nathan
Steven W Yancey
P304
P356
10.1378/CHEST.128.4.1910
P407
P577
2005-10-01T00:00:00Z